Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E P Alessandrino

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|December 16, 1998
Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantationG Martinelli, E P Alessandrino, P Bernasconi, et al.
Anticancer Research|July 1, 1996
Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo)I Buggia, M Zecca, E P Alessandrino, et al.
Annals of Hematology|July 12, 2001
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experienceC Castagnola, E P Alessandrino, M Lunghi, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1982
Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patientsM Lazzarino, E Morra, E P Alessandrino, et al.
Bone Marrow Transplantation|March 7, 2003
Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantationA Locasciulli, B Bruno, E P Alessandrino, et al.
Bone Marrow Transplantation|February 16, 2000
Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignanciesE P Alessandrino, P Bernasconi, A Colombo, et al.
Cancer Genetics and Cytogenetics|September 2, 1998
A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndromeP Bernasconi, P M Cavigliano, E Genini, et al.
Bone Marrow Transplantation|June 1, 2004
A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphomaL Arcaini, E Orlandi, E P Alessandrino, et al.
British Journal of Haematology|February 14, 2002
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphomaM Lazzarino, L Arcaini, P Bernasconi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignanciesA Zambelli, D Lilleri, P Pedrazzoli, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|December 16, 1998
Fournier's gangrene: a clinical presentation of necrotizing fasciitis after bone marrow transplantationG Martinelli, E P Alessandrino, P Bernasconi, et al.
Anticancer Research|July 1, 1996
Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo)I Buggia, M Zecca, E P Alessandrino, et al.
Annals of Hematology|July 12, 2001
Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experienceC Castagnola, E P Alessandrino, M Lunghi, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1982
Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patientsM Lazzarino, E Morra, E P Alessandrino, et al.
Bone Marrow Transplantation|March 7, 2003
Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantationA Locasciulli, B Bruno, E P Alessandrino, et al.
Bone Marrow Transplantation|February 16, 2000
Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignanciesE P Alessandrino, P Bernasconi, A Colombo, et al.
Cancer Genetics and Cytogenetics|September 2, 1998
A complex translocation (5;7) in a patient with acute nonlymphocytic leukemia evolved from a myelodysplastic syndromeP Bernasconi, P M Cavigliano, E Genini, et al.
Bone Marrow Transplantation|June 1, 2004
A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphomaL Arcaini, E Orlandi, E P Alessandrino, et al.
British Journal of Haematology|February 14, 2002
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphomaM Lazzarino, L Arcaini, P Bernasconi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignanciesA Zambelli, D Lilleri, P Pedrazzoli, et al.
Pageof 6